European Pharmaceutical Review
SEPTEMBER 28, 2023
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.
European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
NOVEMBER 26, 2024
said, “India’s pharmaceutical sector is stronger than ever, not only in raw ingredients but also in machinery and biopharmaceuticals. By 2027, biopharma is projected to account for 35 per cent of the global market, positioning India as a leader. Adam Anderson , Executive VP – Pharma, Informa Markets B.V
European Pharmaceutical Review
MAY 1, 2024
Our Ludwigshafen site serves as a centre of excellence for both research and development and pharmaceutical manufacturing and will play a critical role in AbbVie’s future growth,” stated Azita Saleki-Gerhardt , PhD, Executive Vice President, Chief Operations Officer. The new R&D building in Germany is expected to completed in 2027.
pharmaphorum
JANUARY 24, 2022
The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. London, UK. www.highlypotentapi.com/pharmaphorum. Ensuring Risk-Based, Safety-Driven, High-Quality Operation.
Expert insights. Personalized for you.
105 
Let's personalize your content